Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 16138

1.

Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.

McCullough PA, Eidt J, Rangaswami J, Lerma E, Tumlin J, Wheelan K, Katz N, Lepor NE, Vijay K, Soman S, Singh B, McCullough SP, McCullough HB, Palazzuoli A, Ruocco GM, Ronco C.

Rev Cardiovasc Med. 2020 Mar 30;21(1):1-7. doi: 10.31083/j.rcm.2020.01.42.

PMID:
32259899
2.

A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Kutlu Ö, Metin A.

Dermatol Ther. 2020 Apr 7:e13383. doi: 10.1111/dth.13383. [Epub ahead of print] No abstract available.

PMID:
32259878
3.

Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19.

Lütje S, Marinova M, Kütting D, Attenberger U, Essler M, Bundschuh RA.

Nuklearmedizin. 2020 Apr 7. doi: 10.1055/a-1152-2341. [Epub ahead of print]

PMID:
32259853
4.

COVID-19 Outbreak: An Overview.

Ciotti M, Angeletti S, Minieri M, Giovannetti M, Benvenuto D, Pascarella S, Sagnelli C, Bianchi M, Bernardini S, Ciccozzi M.

Chemotherapy. 2020 Apr 7:1-9. doi: 10.1159/000507423. [Epub ahead of print] Review.

PMID:
32259829
5.

How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?

Wei W, Jiang H, Chen W, Zhou Y, Guo S, Zhong G, Zhou H, Wang S, Zhang H, Jiang W, Liu ZG.

Radiother Oncol. 2020 Mar 27;147:100-102. doi: 10.1016/j.radonc.2020.03.016. [Epub ahead of print] No abstract available.

PMID:
32259751
6.

Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist.

Bansal P, Bingemann TA, Greenhawt M, Mosnaim G, Nanda A, Oppenheimer J, Sharma H, Stukus D, Shaker M.

J Allergy Clin Immunol Pract. 2020 Apr 4. pii: S2213-2198(20)30327-5. doi: 10.1016/j.jaip.2020.04.001. [Epub ahead of print] Review.

PMID:
32259628
7.

COVID-19 Infection in italian people with diabetes: lessons learned for our future (an experience to be used).

Gentile S, Strollo F, Ceriello A.

Diabetes Res Clin Pract. 2020 Apr 4:108137. doi: 10.1016/j.diabres.2020.108137. [Epub ahead of print] No abstract available.

PMID:
32259611
8.

The other side of novel coronavirus outbreak: fear of performing cardiopulmonary resuscitation.

Scquizzato T, Olasveengen TM, Ristagno G, Semeraro F.

Resuscitation. 2020 Apr 4. pii: S0300-9572(20)30133-7. doi: 10.1016/j.resuscitation.2020.03.019. [Epub ahead of print] No abstract available.

PMID:
32259607
9.

COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: Prevention and Therapeutic Strategies.

Al-Tawfiq JA, Memish ZA.

Int J Antimicrob Agents. 2020 Apr 4:105968. doi: 10.1016/j.ijantimicag.2020.105968. [Epub ahead of print] No abstract available.

PMID:
32259576
10.

BARICITINIB - A JANUASE KINASE INHIBITOR - NOT AN IDEAL OPTION FOR MANAGEMENT OF COVID 19.

Praveen D, Chowdary PR, Aanandhi MV.

Int J Antimicrob Agents. 2020 Apr 4:105967. doi: 10.1016/j.ijantimicag.2020.105967. [Epub ahead of print] No abstract available.

PMID:
32259575
11.

Interleukin-6 as a potential biomarker of COVID-19 progression.

Ulhaq ZS, Soraya GV.

Med Mal Infect. 2020 Apr 4. pii: S0399-077X(20)30088-3. doi: 10.1016/j.medmal.2020.04.002. [Epub ahead of print] French. No abstract available.

PMID:
32259560
12.

COVID-19 contagion and contamination through hands of trauma patients: what risks and what precautions?

De Vitis R, Passiatore M, Perna A, Proietti L, Taccardo G.

J Hosp Infect. 2020 Apr 4. pii: S0195-6701(20)30175-4. doi: 10.1016/j.jhin.2020.03.037. [Epub ahead of print] No abstract available.

PMID:
32259547
13.

Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong.

Wong SC, Kwong RT, Wu TC, Chan JWM, Chu MY, Lee SY, Wong HY, Lung DC.

J Hosp Infect. 2020 Apr 4. pii: S0195-6701(20)30174-2. doi: 10.1016/j.jhin.2020.03.036. [Epub ahead of print]

PMID:
32259546
14.

Dermatology Residents and the Care of COVID-19 Patients.

Stoj VJ, Grant-Kels JM.

J Am Acad Dermatol. 2020 Apr 4. pii: S0190-9622(20)30509-0. doi: 10.1016/j.jaad.2020.03.086. [Epub ahead of print] No abstract available.

PMID:
32259536
15.

SARS-CoV-2 Vaccines: Status Report.

Amanat F, Krammer F.

Immunity. 2020 Apr 3. pii: S1074-7613(20)30120-5. doi: 10.1016/j.immuni.2020.03.007. [Epub ahead of print] Review.

PMID:
32259480
16.

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.

Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu KM, Chang JH, Kim EJ, Lee S, Casel MAB, Um J, Song MS, Jeong HW, Lai VD, Kim Y, Chin BS, Park JS, Chung KH, Foo SS, Poo H, Mo IP, Lee OJ, Webby RJ, Jung JU, Choi YK.

Cell Host Microbe. 2020 Apr 5. pii: S1931-3128(20)30187-6. doi: 10.1016/j.chom.2020.03.023. [Epub ahead of print]

PMID:
32259477
17.

Calculated decisions: COVID-19 calculators during extreme resource-limited situations.

Steinberg E, Balakrishna A, Habboushe J, Shawl A, Lee J.

Emerg Med Pract. 2020 Apr 6;22(4 Suppl):CD1-CD5.

PMID:
32259419
18.

Novel coronavirus infection in children outside of Wuhan, China.

Shen Q, Guo W, Guo T, Li J, He W, Ni S, Ouyang X, Liu J, Xie Y, Tan X, Zhou Z, Peng H.

Pediatr Pulmonol. 2020 Apr 7. doi: 10.1002/ppul.24762. [Epub ahead of print]

PMID:
32259403
19.

Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: Perspectives from Taiwan.

Chen CC, Chi CY.

Cancer Cytopathol. 2020 Apr 7. doi: 10.1002/cncy.22280. [Epub ahead of print] No abstract available.

PMID:
32259402
20.

Going remote: Maintaining normalcy in our pathology laboratories during the COVID-19 pandemic.

Madrigal E.

Cancer Cytopathol. 2020 Apr 7. doi: 10.1002/cncy.22276. [Epub ahead of print] No abstract available.

PMID:
32259400

Supplemental Content

Loading ...
Support Center